A carregar...
Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk
A CDKN2A/p16 mutation confers 28%–67% lifetime melanoma risk, a risk that may be moderated by ultraviolet radiation exposure. The aim of this study was to test whether melanoma genetic counseling and test disclosure conferred unique informational, motivational, or emotional benefits compared to fami...
Na minha lista:
| Publicado no: | Transl Behav Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065541/ https://ncbi.nlm.nih.gov/pubmed/29385581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/tbm/ibx011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|